BioTech

Thermo Fisher launches $12 billion bid for Qiagen

Credit: REUTERS/© Dado Ruvic / Reuters

Instruments maker Thermo Fisher has launched a 10.4 billion euro ($11.59 billion) bid for genetic testing company Qiagen NV, Qiagen said on Tuesday.

Adds details, context

FRANKFURT, March 3 (Reuters) - Instruments maker Thermo Fisher TMO.N has launched a 10.4 billion euro ($11.59 billion) bid for genetic testing company Qiagen NV QIA.DE, QGEN.N, Qiagen said on Tuesday.

At 39 euros per share, the offer price represents a 23% premium to Qiagen's closing price on March 2, the company said, adding the bid assumed 1.26 billion euros in net debt.

Qiagen in November said it had started to review options, including a sale, after the group received several indications of interest from potential suitors.

($1 = 0.8977 euros)

(Reporting by Christoph Steitz; Editing by Michelle Martin)

((christoph.steitz@thomsonreuters.com; +49 69 7565 1269; Reuters Messaging: christoph.steitz.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

US Markets

Latest Technology Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More